NPPES file of Aug 9, 2026

Reyneiro Castro, MD

Specialist · Pasadena, CA

Reyneiro Castro, MD is a specialist with a practice address in Pasadena, California, and NPI 1457496770, issued on Feb 21, 2007. Check the license (California A72638, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1457496770
Name
Reyneiro Castro
Credential
MD
Primary taxonomy
Specialist 174400000X
License number
A72638 CA
Self-reported in NPPES; status is on the state search
Practice location
301 S Fair Oaks Ave, Pasadena, CA 91105
Phone
(626) 793-6680
Enumerated
Feb 21, 2007
Record last updated
Sep 19, 2023
Fax
(888) 475-7784
Medicare enrollment
Enrolled (PECOS I20050408000624); accepts Medicare assignment
Medical or professional school
University Of California, Davis School Of Medicine, 1998
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 301 S Fair Oaks Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Gary Archer, OMDAcupuncturist1619189396
  2. April August, PA-CPhysician Assistant1831793587
  3. Jack Broussard, D.D.S.General Practice Dentistry1821093832
  4. Kevin Cebula, D.D.S.Orofacial Pain Dentistry1962464040
  5. Kyung A Cho, N.P.Adult Health Nurse Practitioner1740646124
  6. Kay Dabler, SLPSpeech-Language Pathologist1003138199

Verify Reyneiro Castro in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license A72638
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

23% fewer Medicare Part D claims than the average specialist in 2024

1,063 Medicare Part D claims for 183 beneficiaries, against an average of 1,380 among the 8,233 providers of this specialty who prescribed in Part D. Brand-name drugs were 38% of claims.

  1. Reyneiro Castro1,063
  2. Specialty average1,380

Most prescribed

  1. Montelukast Sodium154 claims
  2. Trelegy Ellipta95 claims
  3. Fluticasone Propionate81 claims
  4. Azelastine Hcl75 claims
  5. Albuterol Sulfate Hfa71 claims
  6. Prednisone60 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $1,403.86

69 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 5,844 providers of this specialty with any payment received $4,760.79 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Reyneiro Castro$1,403.86
  2. Specialty average$4,760.79

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Huntington Asthma And Allergy Center A Professional CorporationPasadena, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Specialist providers in California

There are 5,749 specialist records in California.

Other specialist records in California

  1. Fatemeh Abbasi, PTVan Nuys, CA1558496760
  2. Erlinda Abcede, M.D.Cudahy, CA1831228675
  3. Maher Abdallah, M.D.Palm Springs, CA1205988011
  4. Farinaz AbdiSan Marcos, CA1063153963
  5. Mai Abe, LESanta Monica, CA1609405158
  6. Hamid Abedi, HEARING AID SPECIALISan Diego, CA1659410744
  7. Jonas AbellaSan Francisco, CA1679760938
  8. Shreedhar Abhyankar, M.D.Indio, CA1861530669
  9. Elaine AbichRiverside, CA1780458927
  10. Mussarat Abidi, MDLadera Ranch, CA1053307769

Common questions

What is Reyneiro Castro, MD's NPI number?

Reyneiro Castro, MD's National Provider Identifier (NPI) is 1457496770, issued on Feb 21, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Reyneiro Castro, MD located?

The NPPES record lists a practice address at 301 S Fair Oaks Ave, Pasadena, CA, 91105. Phone: (626) 793-6680. Providers update this record themselves, so call before visiting.

How can I verify Reyneiro Castro, MD's license?

NPPES lists California license number A72638, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

How much does Reyneiro Castro, MD prescribe under Medicare Part D?

In 2024, Reyneiro Castro, MD had 1,063 Medicare Part D claims for 183 beneficiaries; the average among specialist prescribers was 1,380. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.